A megtekinteni kívánt tartalom archív.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial
John W. Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj, Brian L. Claggett, Zi Michael Miao, Akshay S. Desai, et al.
Circulation. 2023; 148(24):1945–1957. https://doi.org/10.1161/CIRCULATIONAHA.123.065254